|
|
||||||||
Original Research Communication |
1 From the Departments of Ophthalmology and Child Health, University of Bristol, Bristol, United Kingdom; the Retina Foundation of the Southwest, Dallas; and the Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas.
2 Supported by The Medical Research Council; the Wellcome Trust; The Ministry of Agriculture, Foods and Fisheries; the Departments of Health and the Environment; The South West Regional Health Authority; the National Eye Research Centre; Cow and Gate; and Milupa, all in the United Kingdom. The docosahexaenoic acid assays of maternal blood were carried out by Scotia Pharmaceuticals, Stirling, United Kingdom, at the instigation of DF Horrobin.
3 Address reprint requests to C Williams, Department of Ophthalmology, Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, United Kingdom. E-mail: cathy.williams{at}bristol.ac.uk.
| ABSTRACT |
|---|
|
|
|---|
Objective: The objective of this study was to compare stereoacuity at age 3.5 y in healthy, full-term children who were breast-fed and in similar children who had not been breast-fed after adjustment for socioeconomic status and maternal diet.
Design: Prospectively collected data on maternal diet during pregnancy (including intake of oily fish), the child's diet, and the socioeconomic status of the family were examined. Stereoacuity at age 3.5 y was assessed.
Results: Children who had been breast-fed for 4 mo were more likely to achieve high-grade stereopsis, or stereoscopic vision, than were children who had not been breast-fed (adjusted odds ratio: 2.77; 95% CI: 1.54, 4.97). The mother's antenatal blood DHA content was associated with her intake of oily fish (P < 0.0001). Children whose mothers ate oily fish during pregnancy were also more likely to achieve high-grade stereopsis than were children whose mothers did not eat oily fish (adjusted odds ratio: 1.57; 95% CI: 1.00, 2.45).
Conclusions: The results of this study suggest that for full-term infants, breast-feeding is associated with enhanced stereopsis at age 3.5 y, as is a maternal DHA-rich antenatal diet, irrespective of later infant feeding practice.
Key Words: Stereoacuity breast-feeding docosahexaenoic acid DHA oily fish intake visual development antenatal diet full-term children preterm children
| INTRODUCTION |
|---|
|
|
|---|
The benefits of breast-feeding compared with formula feeding have been attributed by many researchers to the presence of the long-chain polyunsaturated fatty acid called docosahexaenoic acid (DHA). DHA is an important structural component of photoreceptor and cortical neuronal membranes (9, 10). The richest source of DHA in adult diets is fish, particularly fish oil (11). Preformed DHA is present in breast milk but is not available in most commercial formula milks (12, 13).
In the observational studies that had conflicting results on breast-feeding compared with formula-feeding and the effects on visual development, potentially confounding factors included socioeconomic status (14) and variability in the infants' DHA status at birth, which is itself dependent on maternal diet in pregnancy (15, 16) and may affect the infant's later tissue DHA concentrations (17).
The present study was designed in collaboration with an ongoing, prospective population birth cohort study called the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC; 18). The ALSPAC cohort comprises children born in a geographically defined area between 1 April 1991 and 31 December 1992. Eighty-five percent (
14000) of eligible children were recruited into the study during their mother's pregnancy and extensive data on them are available. Further details and a publication list are available on the ALSPAC World Wide Web site (19). The hypothesis under test was that for healthy children born at term, a history of breast-feeding would precede better stereoacuity development than would a history of feeding with formula foods that did not contain DHA, after control for socioeconomic factors and maternal diet in pregnancy (as a proxy for the infant's DHA status at birth). Stereoacuity was chosen as the visual outcome of interest because in the absence of a visual defect (eg, strabismus), it is a cortical phenomenon and might be expected to reflect differences between individuals in the maturity of the visual cortex.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Socioeconomic data were collected via self-completed questionnaires during pregnancy. Maternal dietary information was also collected during pregnancy via a food-frequency questionnaire filled in by the mother at 32 wk gestation. The food-frequency questionnaire asked about the frequency of consumption of 43 different foods, including white fish (cod, haddock, plaice, and fish fingers) and oily fish (pilchards, sardines, mackerel, tuna, herring, kippers, trout, and salmon). For some of the mothers in the ALSPAC cohort, blood samples obtained by venipuncture at the enrollment clinic were available. These samples were collected in heparin-containing tubes, centrifuged at 1500 x g for 15 min at 4°C to separate them into plasma and red or white cells, and then frozen at -20°C. The percentage of DHA as a proportion of the total fatty acid content of the red blood cell membrane phospholipds was measured by gas chromatography in the laboratory of Scotia Pharmaceuticals (Stirling, United Kingdom); the laboratory staff were blind to the results. These data were used to ascertain the extent to which the data from the questionnaires reflected differences in the amount of DHA in the mothers' blood cells. Questionnaires asking about infant feeding practices were completed on behalf of the child at ages 4 wk and 6 mo and a detailed prospective dietary diary describing the child's intake over 24 h was completed when the children were aged 4 mo.
Further details of the questionnaires and their design are available on the ALSPAC Web site (19). The relevant questionnaires are "Your Pregnancy" (administered at 32 wk gestation), on maternal education, maternal diet during pregnancy, and maternal worries about financial matters; "Your Environment" (administered on enrollment between 8 and 28 wk), on type of housing; "Looking After the Baby," on maternal smoking at 8 mo after the birth; "My Young Baby Boy/My Young Baby Girl" at 4 wk and "My Son/My Daughter" at 6 mo, on infant feeding practices; and "My Three-Year-Old Son/Daughter," on the child's diet. During the study period, no formula milks supplemented with DHA were commercially available in the United Kingdom. Information on the child's postnatal diet at age
36 mo was collected via a food-frequency questionnaire completed by the mother. The study was carried out according to the guidelines of the Declaration of Helsinki.
The statistical analysis of the main research question was carried out with use of the Mantel-Haenszel chi-square test for trend followed by forward stepwise logistic regression using SPSS for WINDOWS (version 7.5; SPSS Inc, Chicago). In logistic regression analyses, the outcome must be dichotomous (rather than ordinal, as our stereopsis data were) and so was defined as foveal (or high-grade) compared with nonfoveal. The breast-feeding history was inputed to the model first; the other variables were then inputed and were retained only if they significantly improved the fit of the model to the data. Multiple regression was used to explore relations between potential explanatory variables and the mother's DHA concentration. Analysis of variance (ANOVA) was used to compare DHA concentrations between groups of women according to frequency of intake of oily fish. Where the data were available, the child's stereotest scores were compared with the mother's DHA concentrations with use of a nonparametric test for correlation (Spearman's). A two-tailed P value of <0.05 was considered to be significant.
| RESULTS |
|---|
|
|
|---|
3.5 y (
± SD: 43.2 ± 0.6 mo) were assessed with the new stereoacuity test, of whom 55 (8.6%) were excluded from the analysis because of a strabismus, reduced vision, or high refractive error, which would be expected to reduce stereoacuity. Sixty-nine children (10.7%) were excluded because of missing dietary data and 66 children (10.3%) could not comply with the test (ie, refused to wear the goggles or did not know the names of the items pictured). A further 16 whose gestation period was <37 wk were excluded. Of the remaining 435 full-term children with complete data sets, foveal stereoacuity was achieved by 150 (34.5%), macular stereoacuity by 229 (52.6%), and peripheral stereoacuity by 56 (12.9%). The distribution of the individual scores is shown in Figure 1
|
|
|
4-mo category (adjusted odds ratio: 2.77; 95% CI: 1.54, 4.97), compared with a diet without breast milk. The only other variable retained in the model was whether the mother ate oily fish. The mothers who ate oily fish at least once every 2 wk during pregnancy were more likely to have children who achieved foveal stereoacuity than were the mothers who never ate oily fish (adjusted odds ratio: 1.57; 95% CI: 1.00, 2.45). There was no statistical evidence of interaction between the effects on stereoacuity of whether or not the mother ate oily fish or of breast-feeding compared with formula feeding. When only the children whose mothers never breast-fed (n = 101) were selected, foveal stereoacuity in the children (n = 20) was still more likely if the mothers ate oily fish during pregnancy than if they did not, although the difference was not significant (adjusted odds ratio: 1.26; 95% CI: 0.47, 3.35). The univariate associations that were initially observed between stereoacuity and both maternal age and the child eating oily fish (Table 1
|
|
| DISCUSSION |
|---|
|
|
|---|
The association between the mother's DHA concentrations and her frequency of consumption of oily fish is consistent with the suggestion that the DHA in oily fish may be responsible for the effect on stereoacuity. The association with stereoacuity was specific to the question about oily fish, which may be because oily fish has
10 times more DHA than does white fish or shellfish (22). The human fetus can synthesize DHA precursors from 18 to 22 wk gestation (23) and preterm human infants have the capacity to synthesize DHA from essential fatty acids (24). However, both preterm (2, 2528) and full-term (6, 29) infants who are fed formula milks that lack preformed DHA have lower concentrations of DHA in plasma and red blood cells than do breast-fed or DHA-supplemented infants. Cortical tissues in breast-fed infants also have higher amounts of DHA than do those in formula-fed infants (30, 31). These data suggest that the synthetic capacity of preterm and full-term infants may not be able to meet the demand for DHA in early development. If so, it would be expected that additional supplies of DHA in breast milk or from the mother's diet via the placenta anenatally might be associated with improved neurologic outcomes in full-term children, as seen in this study.
There is already consistent evidence that DHA supplements in formula milks lead to better visual acuity in preterm infants, but there is controversy about the effect of DHA supplements for children born at term on visual acuity. Several randomized controlled trials in preterm infants showed that infants who are fed with DHA-supplemented formula foods have higher visual acuities at age 2 or 4 mo, or both, than do infants who are fed nonsupplemented foods (2, 32, 33). One randomized controlled trial that compared the outcome of feeding full-term infants with DHA-supplemented milks or nonsupplemented milks showed no differences in visual acuity at 2, 4, 6, 9, or 12 mo of age (34). However, other similar randomized controlled trials showed enhanced visual functions in DHA-supplemented groups of full-term children at ages 16 and 30 wk (35) or at ages 6, 17, and 52 wk (29). The discrepancies between the results of these randomized studies in children born at term may be due to differences in the DHA or linolenic acid content of the formula milks used, to variations in visual-acuity testing procedures, or to inadequate sample sizes in the studies that showed no effect. The analysis presented in this article had too few mothers with the relevant data to test fully the post hoc hypothesis that maternal DHA status in pregnancy affects stereoacuity in the child at age 3.5 y, and further data and studies are necessary. However, the correlation between higher maternal DHA concentrations and better stereoacuity scores in the children might suggest that increased maternal DHA concentrations in pregnancy could allow increased transfer of DHA from the mother to the fetus, with subsequent developmental benefits.
The ability to control for socioeconomic variables and maternal diet (as a proxy for DHA status at birth) and the use of stereoacuity as the outcome may explain why an effect of breast-feeding on visual development in full-term children was seen in this study but not in some earlier studies. Stereoacuity is a central phenomenon that may better reflect the maturity of the visual system in young children than does visual acuity. However, as with other observational studies, these results may have been affected by confounding variables that were unknown and thus not accounted for, and the observation of an association gives no proof of causality. DHA concentrations are correlated with other markers of a healthy lifestyle (36) that might themselves affect visual function. The DHA concentrations of the women in the present study were higher than were those in the whole ALSPAC cohort, which may be due to socioeconomic or health-awareness factors. Other nutrients that are present in oily fish, such as eicosapentanoic acid and fat-soluble vitamins, could also have had effects on development. Stereopsis testing for a child aged 3.5 y is difficult and the repeatability of the test was only moderately reliable, as shown by the intraclass correlation coefficient of 0.39. This study used proxy measures for prenatal (maternal intake of oily fish) and postnatal (breast- or bottle feeding) DHA availability because, for most of the children, insufficient data were available for comparison of maternal DHA concentrations in pregnancy, or DHA concentrations in the infant, directly with the child's stereoacuity. However, the use of the question on consumption of oily fish as an indicator of maternal DHA status is supported by the correlation between the frequency of intake of oily fish with the amount of DHA in the maternal red blood cell membranes (Figure 1
). The effects of maternal fish intake on breast-milk DHA content are well described (12, 13, 37).
Further work within ALSPAC will repeat these analyses in a much larger sample with use of both direct and proxy measures of DHA and neurologic outcomes (including stereoacuity) measured at 78 y, when testing is likely to be more accurate. However, the findings described in this article support current efforts to investigate the neurologic benefits of breast-feeding for full-term and preterm infants. They also suggest for the first time an association between maternal diet during pregnancy and a child's visual status at age 3.5 y. Further research is needed to determine whether a child's DHA status at birth is the mechanism by which this is achieved and, if so, whether there is a minimum DHA requirement for mothers during pregnancy for optimal neurologic development.
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. R Rudnicka, C. G Owen, M. Richards, M. E. Wadsworth, and D. P Strachan Effect of breastfeeding and sociodemographic factors on visual outcome in childhood and adolescence Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1392 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A Dunstan, K Simmer, G Dixon, and S L Prescott Cognitive assessment of children at age 21/2 years after maternal fish oil supplementation in pregnancy: a randomised controlled trial Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2008; 93(1): F45 - F50. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singhal, R. Morley, T. J Cole, K. Kennedy, P. Sonksen, E. Isaacs, M. Fewtrell, A. Elias-Jones, T. Stephenson, and A. Lucas Infant nutrition and stereoacuity at age 4-6 y Am. J. Clinical Nutrition, January 1, 2007; 85(1): 152 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L Jensen Effects of n-3 fatty acids during pregnancy and lactation Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1452 - 1457S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Chong, Y. Liang, D. Tan, G. Gazzard, R. A. Stone, and S.-M. Saw Association Between Breastfeeding and Likelihood of Myopia in Children JAMA, June 22, 2005; 293(24): 3001 - 3002. [Full Text] [PDF] |
||||
![]() |
S. Leary, A. Ness, P. Emmett, G. Davey Smith, and ALSPAC Study Team Maternal diet in pregnancy and offspring height, sitting height, and leg length J. Epidemiol. Community Health, June 1, 2005; 59(6): 467 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Hoffman, R. C. Theuer, Y. S. Castaneda, D. H. Wheaton, R. G. Bosworth, A. R. O'Connor, S. E. Morale, L. E. Wiedemann, and E. E. Birch Maturation of Visual Acuity Is Accelerated in Breast-Fed Term Infants Fed Baby Food Containing DHA-Enriched Egg Yolk J. Nutr., September 1, 2004; 134(9): 2307 - 2313. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Rogers, P Emmett, A Ness, and J Golding Maternal fish intake in late pregnancy and the frequency of low birth weight and intrauterine growth retardation in a cohort of British infants J. Epidemiol. Community Health, June 1, 2004; 58(6): 486 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Lutter and J. A. Rivera Nutritional Status of Infants and Young Children and Characteristics of Their Diets J. Nutr., September 1, 2003; 133(9): 2941S - 2949. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Carver Advances in nutritional modifications of infant formulas Am. J. Clinical Nutrition, June 1, 2003; 77 (6): 1550S - 1554S. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Helland, L. Smith, K. Saarem, O. D. Saugstad, and C. A. Drevon Maternal Supplementation With Very-Long-Chain n-3 Fatty Acids During Pregnancy and Lactation Augments Children's IQ at 4 Years of Age Pediatrics, January 1, 2003; 111(1): e39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Williams, K Northstone, R A Harrad, J M Sparrow, I Harvey, and ALSPAC Study Team Amblyopia treatment outcomes after screening before or at age 3 years: follow up from randomised trial BMJ, June 29, 2002; 324(7353): 1549 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. LARQUE, H. DEMMELMAIR, and B. KOLETZKO Perinatal Supply and Metabolism of Long-Chain Polyunsaturated Fatty Acids: Importance for the Early Development of the Nervous System Ann. N.Y. Acad. Sci., June 1, 2002; 967(1): 299 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E Birch, D. R Hoffman, Y. S Castaneda, S. L Fawcett, D. G Birch, and R. D Uauy A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age Am. J. Clinical Nutrition, March 1, 2002; 75(3): 570 - 580. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |